![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07D 495/04 | |
C07D 401/14 | |||
C07D 403/14 | |||
C07D 471/04 | |||
A61K 31/407 | |||
A61P 19/02 |
(11) | Patento numeris | 3110805 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 15755573.1 |
Europos patento paraiškos padavimo data | 2015-02-25 | |
(97) | Europos patento paraiškos paskelbimo data | 2017-01-04 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2019-12-11 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2015/017609 |
Data | 2015-02-25 |
(87) | Numeris | WO 2015/130854 |
Data | 2015-09-03 |
(30) | Numeris | Data | Šalis |
201461944189 P | 2014-02-25 | US | |
201462022916 P | 2014-07-10 | US | |
201462046783 P | 2014-09-05 | US |
(72) |
PHADKE, Avinash, S., US
WANG, Xiangzhu, US
CHEN, Dawei, US
HASHIMOTO, Akihiro, US
GADHACHANDA, Venkat, Rao, US
PAIS, Godwin, US
WANG, Qiuping, US
AGARWAL, Atul, US
DESHPANDE, Milind, US
WILES, Jason, Allan, US
|
(73) |
Achillion Pharmaceuticals, Inc.,
300 George Street, New Haven, CT 06511,
US
|
(54) | COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS |
COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS |